| Date Filed | Type | Description |
| 11/19/2014 |
SC 13D/A
| Canaan VIII LP reports a 0% stake in DURATA THERAPEUTICS, INC. |
| 11/19/2014 |
SC 13D/A
| AISLING CAPITAL III LP reports a 0% stake in Durata Therapeutics, Inc. |
| 11/19/2014 |
SC 13D/A
| New Leaf Ventures II, L.P. reports a 0% stake in Durata Therapeutics, Inc. |
| 11/17/2014 |
8-K
| Quarterly results |
| 11/17/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 11/17/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 11/13/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/07/2014 |
10-Q
| Quarterly Report for the period ended September 30, 2014 |
| 11/04/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/31/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/31/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/24/2014 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/24/2014 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/17/2014 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 10/17/2014 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 10/09/2014 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/08/2014 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 10/06/2014 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer: |
| 10/06/2014 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits|
Docs:
|
"Agreement and Plan of Merger, by and among Actavis W.C. Holding Inc., Delaware Merger Sub, Inc. and Durata Therapeutics, Inc",
"Tender and Support Agreement, by and among Actavis W.C. Holding Inc., Delaware Merger Sub, Inc and certain stockholders of Durata Therapeutics, Inc",
"Actavis to Acquire Durata Therapeutics, Inc." |
|
| 10/06/2014 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 08/28/2014 |
8-K
| Entry into a Material Definitive Agreement |
| 08/28/2014 |
8-K
| Resignation/termination of a director |
| 08/22/2014 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 08/07/2014 |
10-Q
| Quarterly Report for the period ended June 30, 2014 |
| 08/07/2014 |
8-K
| Quarterly results |
| 08/01/2014 |
8-K
| Entry into a Material Definitive Agreement |
| 06/02/2014 |
8-K
| Entry into a Material Definitive Agreement |
| 05/28/2014 |
SC 13D/A
| AISLING CAPITAL III LP reports a 8.6% stake in Durata Therapeutics, Inc. |
| 05/21/2014 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 05/08/2014 |
10-Q
| Quarterly Report for the period ended March 31, 2014 |
| 05/08/2014 |
8-K
| Quarterly results |
| 04/16/2014 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/04/2014 |
SC 13D/A
| SOFINNOVA VENTURE PARTNERS VII L P reports a 6.7% stake in Durata Therapeutics, Inc. |
| 03/24/2014 |
SC 13D/A
| AISLING CAPITAL III LP reports a 11.4% stake in Durata Therapeutics, Inc. |
|